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ABSTRACT 
DEVELOPMENT OF ENZYME-LINKED IMMUNOSORBENT ASSAYS FOR THE 
DETECTION OF MUTAGENIC METABOLITES OF THE HERBICIDE ALACHLOR 
FEBRUARY 1998 
DANIEL M. TESSIER 
B.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor J. Marshall Clark 
The herbicide alachlor is one of the most widely used pesticides in the world; over 52 
million pounds are applied to U.S. croplands annually. The acetanilide compounds 2- 
chloro-2',6'-diethylacetanilide (CDA) and 2-hydroxy-2',6'-diethylacetanilide (HDA) are 
environmental degradative products of alachlor. CDA, HDA and alachlor are ground and 
surface water contaminants; CDA and HDA are mutagenic in the Salmonella / microsome 
assay. There is a paucity of data on the environmental fate of CDA and HDA. 
The development of two competitive enzyme-linked immunosorbent assays (cELISA) 
for the detection of CDA and HDA is reported. cELISA3 is specific for CDA with a 
detection range of 0.015 to 10 pg/ml. Solid phase extraction of CDA residues from 
aqueous samples gives a 1000-fold concentration factor resulting in an effective detection 
limit of 15 pg/ml. cELISA4 is specific for both CDA and HDA in combination, with a 
detection range of 0.01 to 10 pg/ml. Solid phase extraction of aqueous samples prior to 
cELISA analysis results in an effective detection limit of 10 pg/ml. Chloroacetanilide 
vi 
herbicides and other alachlor metabolites that may be present in environmental samples 
do not interfere with the detection of CDA and HDA. 
cELISA3, cELISA4 and the antisera they are based on provide a means of studying the 
environmental fate of CDA and HDA through a variety of analytical strategies. 
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A. The Herbicide Alachlor 
1. Status of Alachlor Use 
The chloroacetanilide herbicide alachlor is one of the most extensively-used 
agrochemicals in the United States of America (USA). It is a selective, preemergent 
herbicide used on com, soybean, sorghum and other crops for broadleaf weed control. 
Alachlor is manufactured by Monsanto Agricultural Company (St. Louis, MO) under the 
trade names Lasso™, Lasso II™ and Lasso Micro-Tech™ and is also formulated in 
mixtures with atrazine, glyphosate, propanil, and other herbicides. Approximately 95 
million pounds were applied annually to American croplands during the peak of alachlor 
use in the late 1970s to early 1980s (EPA 1987, Sun 1986). Current use patterns have 
decreased to approximately 52 million pounds applied annually (Gianessi and Anderson 
1995). However, alachlor still ranks third, after atrazine (72 million pounds applied / 
year) and metolachlor (59 million pounds applied / year), in total usage per year for all 
pesticides. In the USA, alachlor is applied to 30% of sweetcom acreage, 20% of feed 
com acreage, 10% of soybean and sorghum acreage, and less than 10% of cotton and 
peanut acreage (Gianessi and Anderson 1995). 
2. Magnitude and Significance of Environmental Contamination 
Numerous studies, conducted by the U.S. Environmental Protection Agency (EPA), 
U.S. Department of Agriculture (USDA), U.S. Geological Survey (USGS), and Monsanto 
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have shown alachlor to be a commonly detected contaminant in ground and surface 
waters. It is moderately soluble in water and exhibits other chemical properties that 
contribute to its mobility in the environment (Table 1). Contamination of ground and 
surface water by alachlor occurs via leaching through the soil profile (groundwater) and 
overland flow (surface water) in the dissolved state. Contaminated groundwater also 
significantly contributes to surface water contamination (Pereira and Rostad 1990; Pereira 
et al. 1992; Pereira and Hostettler 1993; Thurman et al. 1996). Volatilization from the 
soil surface results in detectable residues of alachlor in fog and rainwater, where they are 
dispersed and redeposited on land and water surfaces (Goolsby et al. 1997). 
Table 1. Selected EPA Leaching Criteria and Chemical Parameters for Alachlor 
Parameter EPA Leacher Alachlor 
Water solubility >30 mg/L 242 mg/L 
Kd1 <5 0.3 -3.7 
Hydrolysis half-life > 180 d stable 
Photolysis half-life >3 d stable 
Soil half-life > 14-21 d 6-23 d 
1. Soil/water adsorption coefficient. 
Refs: Montgomery 1993; Wienhold and Gish 1994. 
Groundwater contamination, typically in the low part per billion range, has been 
reported in at least 24 of 34 states where alachlor is used (Jacoby et al. 1992). The 
frequency of detection is 0.1 to 5% of all wells tested. In studies that focused on areas of 
heavy alachlor use, however, upwards of 75% of private wells are contaminated with 
alachlor (Chesters et al. 1989). Surface waters are also significantly impacted by alachlor. 
The Mississippi River, the major water drainage system in the central USA, receives a 
2 
complex mixture of agrochemicals from this primarily agricultural region. It is estimated 
that the Mississippi River annually transports 18 tons of alachlor into the Gulf of Mexico 
(Pereira and Hostettler 1993). 
Although the acute mammalian toxicity of alachlor is relatively low (LD50 = 930 mg/kg, 
oral, rat), it is a proven animal carcinogen. The EPA designates alachlor as a class B2 
carcinogen or "probable human" carcinogen. Therefore, the contamination of ground and 
surface waters by alachlor may be regarded as toxicologically significant from the 
perspective of chronic human exposure via drinking water supplies. 
The presence of alachlor in ground and surface water, coupled with its oncogenicity, 
resulted in an outright banning of this herbicide by Canada in 1985 (Hoberg 1990). 
Although registered as a ‘"restricted use” agrochemical in the USA, alachlor is still one of 
the most heavily applied pesticides and a significant ground and surface water 
contaminant. 
B. Environmental Metabolism of Alachlor 
The study of the chemistry, fate, transport and analysis of environmental metabolites of 
pesticides has historically not received as much attention as research on the parent 
pesticides themselves. This has been due to the large number of potential analytes arising 
from the breakdown of any given parent compound, coupled with a backlog of 
environmental research still needed for existing and newly developed pesticides. 
Degradation in the environment, whether biotic, abiotic or photolytic, most commonly 
results in compounds that retain the structural core of the parent pesticide. These 
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degradation products may retain some of the activity of the parent and / or exhibit 
mechanisms of toxicity unrelated to the mode of action of the parent (Barrett 1996). 
Metabolites are typically more stable and more polar than the parent compound and 
therefore more mobile in the environment. In this manner, metabolites can have an even 
greater impact on ground and surface waters than the parent compound. Except for the 
sulfoxide and sulfone metabolites of aldicarb, there are no established tolerances for 
pesticide metabolites in water (Barbash and Resek 1996). 
The biotic, primarily microbial, degradation of alachlor results in a variety of aromatic 
amine metabolites that also have been detected in ground and surface waters (Fig. 1; 
Potter and Carpenter 1995, Pereira and Hostettler 1993, Pereira et al. 1992, Pereira and 
Rostad 1990, Aizawa 1982, Tiedje and Hagedorn 1975). Abiotic oxidative metabolism 
plays only a minimal role in degradation and mineralization does not occur (Novick 
1986). Thus, movement of these metabolites out of the microbially active zone of the soil 
profile (i.e., the rhyzosphere) may result in some of these metabolites existing as long¬ 
term or terminal residues with the potential to contaminate ground and surface waters. 
Alachlor has been detected in the rhyzosphere for up to one year after application 
(Heyer and Stan 1995), thus providing a long-term input for metabolite formation. Potter 
and Carpenter (1995) identified 20 distinct compounds in groundwater samples that were 
postulated to arise from alachlor degradation. The major metabolites of alachlor that 
have been studied to date are alachlor-ethanesulfonic acid [ESA; (Thurman et al. 1996, 
Baker et al. 1993)], 2-chloro-2',6'-diethylacetanilide [CDA; (Potter and Carpenter 1995, 
Pereira and Hostettler 1993, Pereira et al. 1992, Pereira and Rostad 1990)] and 
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Figure 1. Environmental degradative products of alachlor. I: alachlor; II: 2-hydroxy-2',6'- 
diethyl-N-methoxymethylacetanilide; III: 2,6-diethyl-N-methoxymethylacetanilide; IV: 
2,6-diethyl-N-methoxymethylaniline; V: 2-chloro-2',6'-diethylacetanilide; VI: 2-hydroxy- 






2-hydroxy-2',6'-diethylacetanilide [HDA; (Potter and Carpenter 1995)]. These compounds 
exhibit environmental mobility and have been detected in both ground and surface waters 
at part per trillion levels. Nevertheless, the rate of formation, persistence, movement and 
ultimate environmental fate for these and other metabolites of alachlor is unknown. 
It is also unknown how evolving agricultural practices are influencing metabolite 
formation. For example, controlled-release formulations are used to reduce herbicide 
leaching (Lee and Weber 1993). Controlled-release formulations enhance the retention of 
pesticides in the rhyzosphere, providing enhanced efficacy and allowing a reduction in 
application rates. The rhyzosphere is the primary site of pesticide degradation, however, 
so this strategy may result in elevated levels of metabolite formation. Another example is 
addition of conditioners or adjuvants to irrigation water for the reduction of soil erosion 
(Sojka and Lentz 1993; Weitersen et al. 1993). This practice may also enhance the 
retention of pesticides in the rhyzosphere by modifying the sorptive characteristics of the 
soil, resulting in elevated levels of metabolite formation. In other reports, soil microbes 
have been shown to selectively use adjuvants as carbon sources leaving the pesticide 
unchanged and available for groundwater contamination. Thus, the overall influence of 
soil conditioning practices and controlled-release formulations must be assessed to insure 
that the net result is not an increase in metabolites reaching ground and surface water 
sources, particularly when they are toxic themselves. 
C. Mutagenicity of Alachlor Metabolites 
The acute mammalian toxicities of herbicides and fungicides are relatively low 
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compared to insecticides. However, there is little information to describe the toxic 
potential of their metabolites. Chronic human exposure can occur through contaminated 
ground or surface waters that serve as potable water supplies. Soil-dwelling and aquatic 
organisms can also be chronically exposed to these metabolites, resulting in the 
possibility of bioaccumilation and biomagnification. 
The chronic toxicity potential of environmental metabolites of alachlor was evaluated 
by Tessier and Clark (1995) utilizing the Salmonella / microsome assay (Maron and 
Ames 1983) and the micronucleus assay (Hayashi et al. 1990). Two metabolites, 2- 
chloro-2',6'-diethylacetanilide (CDA, V, Fig. 1) and 2-hydroxy-2',6'-diethylacetanilide 
(HDA, VI, Fig. 1), were determined to be weakly mutagenic to Salmonella strain TA100. 
This strain is sensitive to point mutations. Mutagenicity of CDA was independent of, but 
enhanced by, microsomal monooxygenase bioactivation, whereas HDA was dependent on 
bioactivation to elicit its mutagenic effects. Thus, CDA is a direct-acting mutagen and 
HDA is a promutagen. 
It was hypothesized that the mechanism of action of CDA and HDA is through 
bioactivation to electrophilic species, which then covalently react with nucleophilic 
DNA/RNA to form alkylated or otherwise structurally altered forms of the genetic 
material (Fig 2). The glutathione S-tranferases (GST) are a family of detoxifying 
enzymes. They are primarily responsible for the deactivation of electrophilic species by 
conjugating them to glutathione and forming water-soluble, excretable adducts (Jakoby 
1978). Experiments with GST showed a decrease in the mutagenicity of HDA, 
presumably by GST conjugation (Tessier and Clark 1995). This finding supports the 
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Figure 2. Proposed mechanism of action of CDA and HDA as toxic electrophiles. In the 
figure X = -Cl (in CDA) or -OH (in HDA). Cytochrome P450-based dechlorination or 
dehydroxylation results in electrophilic species that react with nucleophilic DNA or RNA 




proposed mutagenic mechanism of CDA and HDA as toxic electrophiles. Since CDA 
caused mutations without bioactivation at high doses, other mechanisms may also play a 
role. Results of murine micronucleus tests indicate that these compounds do not have 
clastogenic activity (Tessier and Clark 1995). Their genotoxicity is thus limited to 
specific molecular interactions with DNA/RNA, forming point mutations. Since 
mutagenesis commonly precedes carcinogenesis, the mutagenic metabolites of alachlor 
are very likely to play a role in the carcinogenicity of alachlor. Therefore, the 
quantitation of the overall environmental impact of alachlor use in agriculture should 
include the added burden of ground and surface water contamination by the toxic 
metabolites CDA and HDA. 
D. Cross-Reactivity of CDA and HDA Mutagens in Alachlor Immunoassays 
Immunoassay kits are currently available for the detection of alachlor in ground and 
surface waters. Alachlor residue levels measured by these kits show a slight positive bias 
when compared to chromatographic analysis of the same samples. This indicates a 
degree of cross-reactivity to structurally-related compounds, notably alachlor soil 
metabolites and, in particular, the ethanesulfinic acid (ESA) metabolite (Baker et al. 
1993). It was determined that CDA and HDA are not cross reactive in three 
commercially available immunoassay kits (i.e., Ohmicron, Agri-Diagnostics, and 
Millipore; Tessier 1994). Therefore, these toxicologically significant metabolites are not 
included in the quantitation of alachlor contamination via monitoring schemes based on 
currently available immunoassays. 
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E. Utility of an Alachlor Metabolite Immunoassay 
CDA and HDA have been detected in ground and surface waters in the course of 
monitoring for alachlor and other major use herbicides. However, there are relatively 
little data on the incidence of these compounds in other environmental compartments, or 
the overall extent of their incidence in the environment. Additionally, there are virtually 
no data concerning the rate of formation, movement, persistence, and further degradation 
of these mutagens. In addition to the overall impact that CDA and HDA may have on 
organisms exposed to these mutagens in soils and water, there is the additional potential 
for chronic human exposure from contaminated drinking water supplies and via 
bioaccumilation. 
The development of immunoassay technology specifically directed at the detection of 
CDA and HDA was deemed meritorious in that it would provide a sensitive, fast, 
inexpensive means of measuring the incidence of these known mutagens in 
environmental matrices. This in turn would provide a better understanding of their 
environmental fate and whether operational factors, such as formulation type or soil 
management practices, mitigate or enhance their formation. Ultimately, this will clarify 
how the environmental degradation of alachlor occurs and which environmental factors 
result in the increased formation of mutagenic metabolites. Information on these 
processes will allow the development of strategies that will attenuate the overall risks 
posed by continued use of this carcinogenic herbicide. 
To date, the low level detection of CDA and HDA in water samples has been 
accomplished by gas chromatography with ion-trap mass spectrometry (Pereira et al. 
12 
1990). While this methodology allows determination of part per trillion level residues in 
water samples, the cost of instrumentation and the skill level required to operate it is 
prohibitive for significant, large-scale monitoring programs. Immunoassays specific for 
CDA and HDA would compliment this chromatographic analysis by providing the ability 
to screen large numbers of samples quickly and inexpensively. More involved analytical 
procedures can thus be performed as confirmation of a much smaller set of positive 
samples. 
A new direction in environmental analysis exploits the specific binding properties of 
antibodies as immunosorbents in sample pretreatment (Henion et al. 1997). Antibodies 
bound to a solid support can be used as a solid-phase extraction mechanism. Therefore, 
analyte-specific or chemical class-specific concentration and cleanup of samples for 
traditional instrumental analyses is possible. The availability of CDA and HDA specific 
antibodies will make this new analytical strategy possible for these toxicologically 
significant alachlor metabolites. 
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CHAPTER II 
SYNTHESIS OF HAPTENIC DERIVATIVES FOR THE 
PREPARATION OF CDA AND HDA IMMUNOGENS 
A. Chemicals 
2,6-Diethylaniline, ethyl chloroacetate, chloroacetyl chloride, 4-ethylphenol, 
aluminum chloride and sodium nitrite were obtained from Aldrich Chemical Co. 
(Milwaukee, WI). N-hydroxysuccinimide (NHS), N,N’-dicyclohexylcarbodiimide 
(DCC), N-acetyl homocysteine thiolactone (AHT), ethyl 4-bromobutyrate, ethyl 5- 
bromovalerate, bovine serum albumen (BSA), human serum albumen (HSA) and 
ovalbumin (OVA) were obtained from Sigma (St. Louis, MO). Goat anti-rabbit IgG 
conjugated to horseradish peroxidase was obtained from Jackson ImmunoResearch 
Laboratories (West Grove, PA). 2-Chloro-2’,6’-diethylacetanilide (CDA, 99%) and 2- 
hydroxy-2 ,6 -diethylacetanilide (HDA, 99%) were synthesized in the Mass Spectrometry 
Laboratory, College of Food and Natural Resources, University of Massachusetts / 
Amherst (Potter and Carpenter 1995). 
B. Apparatus 
Infrared (IR) analysis was conducted on a Perkin-Elmer 1330 spectrophotometer 
(Norwalk, CT) scanning from 4000 to 200 cm1. Proton nuclear magnetic resonance (*H 
NMR) analysis was conducted on a Bruker / IBM 200AC (Karlsruhe, Germany) 
spectrometer operating at 200 MHz. Chemical shifts in ppm are reported compared to a 
tetramethylsilane (TMS) standard. Gas chromatographic / mass spectral (GC/MS) 
14 
analysis was conducted on a Hewlett-Packard 5890 II gas chromatograph / 5971 mass 
selective detector (Palo Alto, CA) equipped with a 30 meter HP-5 column, 0.25 pm film, 
temperature programmed from 70 °C (1 min) to 275 °C (1 min) at 15 C/min. Injector 
temperature was 250 °C, the interface 280 °C, and the mass range scanned from 35 - 550 
mass units. Immunoassays were determined on a Softmax™ Plate Reader (Molecular 
Devices, Sunnyvale, CA). 
C. Synthesis of Haptens 
1. Synthesis of Hapten C2-CDA 
The synthesis of a haptenic derivative of CDA containing a 2-carbon spacer group 
attached to the nitrogen moiety (C2-CDA) for subsequent linkage to carrier protein 
molecules is outlined schematically in Figure 3. Details of the synthetic procedures and 
structural confirmation are described below, 
a. 2,6-Diethylaniline-N-ethyl acetate (2) 
2,6-Diethylaniline (1, 7.5 g; 0.05 mol) and ethylchloroacetate (12.3 g; 0.1 mol) were 
heated with stirring in the presence of Na2C03 (4.2 g; 0.05 mol) for 4 h at 140 °C. The 
reaction mixture was removed from heat and distilled water (dH20; 20 ml) added. Both 
aqueous and organic phases were transferred to a separatory funnel and ethyl acetate (15 
ml) added. The crude reaction mixture was extracted by shaking for 1 min and the 
aqueous phase discarded. The organic phase was washed twice with 1 M HC1 (25 ml) 
and dried over Na2S04. Ethyl acetate was removed from the organic phase by rotory 
evaporation to yield 11.44 g crude 2. The crude product was purified by dry column 
chromatography (63 - 200 pm silica, 40% ethyl acetate : hexane) to yield an 
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Figure 3. Synthesis of hapten C2-CDA (4) containing a 2-carbon spacer group attached 
to the nitrogen moiety. 
16 
H H \ / 
i. ethylchloroacetate 
ii. 0.7 M NaOH 
iii. chloroacetyl chloride 
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amber oil (90%). IR (neat, cm'1): 3380 (N-H), 2960-2865 (alkyl C-H), 1740 (C-O), 
1455 (aryl C=C), 1370-1340 (2° aryl C-N), 1205 (ester C-O-C), 860,750 (1,2,3 trisub. 
aryl C-H). 'H NMR (200 Hz, CDC13): 8 1.2 (t, 9H, -CH3), 2.7 (q, 4H, -CH2-), 3.8 (s, 2H, 
N-CH2-), 4.0 (s, 1H, N-H), 4.2 (q, 2H, -COOCH2-), 7.0 (m, 3H, aryl -CH). GC/MS: tr = 
8.9 min, m/z = 235 (M+), 162, 147. 
b. 2,6-Diethylaniline-N-acetic acid (3) 
2.6- Diethylaniline-N-ethyl acetate (2, 1.0 g) was dissolved in 40 ml 0.7 M NaOH / 
acetone (65:35 v:v). The reaction mixture was stirred at ambient temperature for 14 h. 
Acetone was removed under vacuum and the aqueous mixture acidified (H3PO4) to pH 3- 
4. Crude 3 was extacted with 3 x 20 ml ethyl actetate. The combined solvent extracts 
were dried over Na2S04 and the solvent removed under vacuum. The product was 
purified by dry column chromatography (63 - 200 pm silica, 25 % ethyl acetate : hexane) 
to yield an amber oil (80%). IR (neat, cm"1): 3380 (N-H), 3300 - 2500 (acid O-H), 1730 
(acid C=0), 1450 (aryl C=C), 1400 - 1380 (2° aryl C-N), 1220 (broad, -COOH), 805, 730 
(1,2,3 trisub. aryl C-H). GC/MS (methyl ester): tr = 8.3 min, m/z = 221 (M+), 162, 147, 
132. 
c. 2-Chloro-2’,6’-diethyl(N-acetic acid)acetanilide (4) 
2.6- Diethylaniline-N-acetic acid (3, 1.5 g) was dissolved in 45 ml methylene chloride. 
Chloroacetyl chloride (1 g) in methylene chloride (15 ml) was added dropwise with 
stirring (CAUTION!) to the solution of 3. The reaction continued for 2 h at ambient 
temperature with constant stirring. The reaction mixture was washed with 2 x 25 ml 
dH20, and the organic layer dried over Na2S04. The solvent was removed under vacuum 
to yield 1.4 g of a purple oil. The product was purified by dry-column chromatography 
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(63 - 200 pm silica, 25 % ethyl acetate : hexane) to yield an amber oil (84%). IR (neat, 
cm’1): 3005-2860 (C-H), 3300-2500 (br, O-H), 1735 (CO), 1680 (3° amide C=0), 1450 
(aryl CO), 1430-1380 (3° aryl amine C-N), 1250-1200 (br, -COOH), 800-760 (1,2,3 
trisub. aryl C-H). GC/MS (methyl ester): tr = 11.6 min, m/z = 297 (M+), 248, 188, 160. 
2. Synthesis of Hapten C4-CDA 
The synthesis of a haptenic derivative of CDA containing a 4-carbon spacer group 
attached to the nitrogen moiety (C4-CDA) for subsequent linkage to carrier protein 
molecules is outlined schematically in Figure 4. Details of the synthetic procedures and 
structural confirmation are described below, 
a. 2,6-Diethylaniline-N-ethylbutyrate (5) 
2,6-Diethylaniline (1, 7.5 g, 0.05 mole) and ethyl 4-bromobutyrate (19.5 g, 0.1 mole) 
were stirred at 140 °C for 4 h in the presence of sodium bicarbonate (5.3 g, 0.05 mole). 
The reaction mixture was removed from heat and dH20 (20 ml) added. Both aqueous and 
organic phases were transferred to a separatory funnel and ethyl acetate (15 ml) added. 
The crude reaction mixture was extracted by shaking for 2 min and the aqueous phase 
discarded. The organic phase was washed twice with 1 M HC1 (20 ml), and dried over 
Na2S04. Ethyl acetate was removed from the organic phase by rotory evaporation to 
yield 14 g of a purple-black oil. The crude product was purified by dry column 
chromatography (63 - 200 pm silica, 10% ethyl acetate : hexane) to yield a pale yellow oil 
(90%). IR (neat, cm'1): 2950-2850 (alkyl C-H), 1750 (C=0), 1450 (aryl C=C), 1360 (2° 
aryl C-N), 1250 (ester C-O-C). GC/MS: tr = 11.5 min, m/z = 263 (M+), 218, 162, 148, 
132. 
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Figure 4. Synthesis of hapten C4-CDA (7) containing a 4-carbon spacer group attached 




i. ethyl 4-bromobutyrate 
ii. 0.7 M NaOH 
iii. chloroacetyl chloride 
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b. 2,6-Diethylaninline-N-butyric acid (6) 
2.6- Diethylaniline-N-butyrate (5, 1.0 g) was dissolved in 40 ml 0.7 M NaOH / acetone 
(65:35 v:v). The reaction mixture was stirred at ambient temperature for 18 h. Acetone 
was removed under vacuum and the aqueous mixture acidified (H3PO4) to pH 3-4. Crude 
3 was extacted with 3 x 20 ml ethyl actetate. The combined extracts were dried over 
Na2S04 and the solvent removed under vacuum to yield 0.75 g of a yellow oil. 
c. 2-Chloro-2’,6’-diethyl(N-butyric acid)acetanilide (7) 
2.6- Diethylaniline-N-butyric acid (6, 0.75 g) was dissolved in 25 ml methylene 
chloride. Chloroacetyl chloride (0.9 g) in methylene chloride (6 ml) was added dropwise 
with stirring (CAUTION!) to the solution of 6. The reaction continued for 2 h at 
ambient temperature with constant stirring. The reaction mixture was washed with 3 x 25 
ml dH20, and the organic layer dried over Na2S04. The solvent was removed under 
vacuum to yield 0.75 g of a purple oil that solidified on standing. The product was 
purified by dry-column chromatography (63 - 200 pm silica, 30 % ethyl acetate : hexane) 
to yield 0.6 g white crystals. 
3. Synthesis of Hanten Phe-CDA 
The synthesis of a haptenic derivative of CDA containing a five-carbon spacer group 
attached to the aromatic ring (Phe-CDA) for subsequent linkage to carrier protein 
molecules is outlined schematically in Figures 5 and 6. Details of the synthetic 
procedures and structural confirmation are described below, 
a. 3,5-Diethylphenol (9) 
4-Ethylphenol (8, 50g; 0.41 mole) and aluminum chloride (125g; 0.94 mole) were 
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Figure 5. Synthesis of 2,6-diethyl-4-hydroxyaniline. 
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i. aluminum chloride /110°C/4h 
ii. sodium nitrite 
iii. H2 / Pd catalyst 
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Figure 6. Synthesis of hapten Phe-CDA (14) containing a 5-carbon spacer group attached 








i. ethyl 4-bromobutyrate 
ii. chloroacetyl chloride 
iii. 0.7 MNaOH 
HO 
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heated with stirring at 110 °C + 5 °C for 4 h. The reaction mixture was cooled to 60 C, 
poured onto crushed ice and steam distilled to yield 41g of a crude phenolic mixture 
containing phenol, 3,5-diethylphenol and by-products. The phenolic mixture was 
fractionally distilled under vacuum (15 mm Hg). 3,5-Diethyl- 
phenol, collected as the remaining fraction after removal of phenol and related by¬ 
products, was recrystallized from petroleum ether to yield 3.8g of white, needle crytals 
with a distinct phenolic odor. Melting point, 77 °C. Purity, 99.9% (GC/MS). IR (KBr 
pellet, cm'1): 3320-3180 (s,b, O-H ); 2960, 2940, 2880 (s, CH2, CH3); 1600, 1450 (Ar 
ring). GC/MS: tr = 10.27 min, m/z - 150 (M+), 135 (M-CH3), 121 (M-C2H5). 
b. 3,5-Diethyl-4-nitrosophenol (10) 
3.5- Diethylphenol (9, 3.6g, 24 mmol) was dissolved in reagent ethanol (25 ml) and 
concentrated HC1 (25 ml) was added with stirring. The reaction mixture was cooled to 0 
°C and NaN03 (2.5 g, 30 mmol), dissolved in 3 ml dH20, was added dropwise. The 
reaction was continued for 2 h at 10 °C. The reaction mixture was poured onto ice-water 
and filtered to yield 3.4 g of rust-colored crystals. Melting point, 126 °C (decomp.). IR 
(KBr pellet, cm'1): 3460-2600 (s,b, O-H and -CH2-, -CH3); 1720, 1685, 1655 (Ar ring), 
1500 (s, -N=0), 1140 (s, C-OH), 1000 (C-N). 
c. 2,6-Diethyl-4-hydroxyaniline (11) 
3.5- Diethyl-4-nitrosophenol (10, 3.4 g in 40 ml THF) was hydrogenated at atmospheric 
pressure in the presence of palladium catalyst (380 mg). [CAUTION: The palladium 
catalyst can ignite solvent vapors. The hydrogenation apparatus must be flushed with 
inert gas prior to addition of catalyst.] The hydrogenation reaction continued for 3 h, after 
which the reaction solution was filtered through Celite 545 to remove the catalyst. 
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Removal of the solvent under vacuum yielded 3 g of orange crystals. Melting point, 118 
°C. Purity, 97.6% (GC/MS). GC/MS: tr = 8.4 min, m/z = 165 (M+), 150 (M-CH3), 135. 
Elemental analysis (theoretical values in parentheses): C: 72.38% (72.73); H: 9.3% (9.1); 
N: 8.36% (8.5); O: 9.96% (9.7). 
d. 2,6-Diethyl-4-[4’-(ethoxycarbonyl)butoxy]aniline (12) 
2.6- Diethyl-4-hydroxyaniline (11, 1 g, 6 mmol) was dissolved in 10 ml dimethyl 
sulfoxide. The stirred solution was cooled to 15 °C and potassium hydroxide (0.5 g, 9 
mmol) added. The solution was returned to ambient temperature and ethyl-5 - 
bromovalerate (1.9 g, 9 mmol) was slowly added over the course of 70 min, after which 
the reaction was stopped by pouring the solution into 10 ml 4 MHC1 at 0 °C. The acidic 
solution was extracted with diethyl ether (3 x 50 ml) to remove unreacted ethyl-5 - 
bromovalerate, and then basified with 15 ml 2 MNaOH. The basic solution was 
extracted again with diethyl ether (3x30 ml), the combined ethereal extracts were 
washed with distilled water (2 x 50 ml), brine (2 x 50 ml) and dried over Na2SC>4. The 
solvent was removed under nitrogen to yield 0.3 g of a brown oil. Purity, 99.7% 
(GC/MS). IR (neat, cm'1): 2950 (-CH2-, -CH3), 1725 (C=0, ester), 1590 (-N-H), 1470 (- 
CH2-). GC/MS: tr= 14.14 min, m/z = 293 (M+), 248, 165/164, 129, 101. 
e. 2-Chloro-2’,6’-diethyl-4’-[4”-(ethoxycarbonyl)butoxy]acetanilide (13) 
2.6- Diethyl-4-[4’-(ethoxycarbonyl)butoxy]aniline (12, 0.3 g, 1 mmol) was dissolved in 
10 ml methylene chloride. Chloroacetyl chloride (170 mg, 1.5 mmol, diluted in 1.5 ml 
methylene chloride) was added at room temperature to the stirred solution of 12 in 100 pi 
aliquots at 2 min intervals. The reaction was continued 30 min after the last chloroacetyl 
chloride addition. The reaction mixture was washed with water (3 x 20 ml), followed by 
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brine (3 x 20 ml), dried over Na2S04 and the solvent removed to yield 0.33 g of a brown 
solid. Purity 99.9% (GC/MS). IR (Nujol, cm’1): 3240, 2940, 1740 (s, ester C=0), 1660, 
1600. GC/MS: tr= 15.00 min, m/z = 369 (M+), 129, 101 (M - .C2H5CO.OC2H5). 
Elemental analysis (theoretical values in parentheses): C: 61.55% (61.7), H: 7.57% 
(7.63), N: 3.68% (3.79), Cl: 9.38% (9.58), O: 17.82 (17.30). 
f. 2-Chloro-2’,6’-diethyl-4’-[4”(carboxylic acid)butoxy]acetanilide (14) 
2-Chloro -2’,6’-diethyl-4’-[4’’-(ethoxycarbonyl)butoxy]acetanilide (13, 163 mg, 0.4 
mmol), dissolved in 1 ml acetone, was stirred in the presence of 2 MKOH (1.5 ml) at 
ambient temperature for 24 h. The reaction solution was neutralized with 4 M HC1 and 
extracted with diethyl ether (3x7 ml). The combined extracts were washed with water (2 
x 10 ml), brine (2x10 ml) and dried over Na2SC>4. The solvent was removed under 
vacuum to yield 152 mg of a brown semi-solid. Crude 14 was purified by thin-layer 
chromatography (silica gel, 2000 p, ethyl acetate : hexane : acetic acid, 25:70:5) to yield 
103 mg white crystals. Melting point, 132 °C (decomp). Purity, 99% (TLC). IR (KBr 
pellet, cm'1): 3680-2500 (m, b, acidic -O-H), 3285 (s, amide N-H), 1720 (s, acidic C=0), 
1660. GC/MS (methyl ester): tr = 10.9, m/z = 355 (M+), 192, 115. 
D. Preparation of Hapten-Protein Conjugates 
1. Preparation of Active Esters of the CPA Haptens 
The acid moieties of C2-CDA, C4-CDA and Phe-CDA were modified to activated 
esters to allow spontaneous coupling of the haptens to amine residues on the carrier 
proteins (Fig. 7, Tijssen 1985). 
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a. General method for the formation of active esters 
C2-CDA, C4-CDA or Phe-CDA (0.1 - 0.6 g) and N-hydroxysuccinimide (0.1 - 0.26 g) 
were dissolved in 5 - 10 ml THF. The solution was cooled to 0 °C and N,N - 
dicyclohexylcarbodiimide (50 - 500 mg) was added with stirring. The reaction was 
continued at -20 °C for 24 h. The cold solution was filtered to remove most of the 
dicyclohexyl urea (DCU) that was formed during the reaction. Methylene chloride was 
added to the filtrate, which was washed with 2 x 10 ml dT^O followed by 2 x 10 ml 
saturated NaCl solution. Solvent was removed under vacuum from the dried organic 
layer (Na2S04) to yield an amber, oily-crystalline residue consisting of the activated ester 
and residual DCU. The esters were purified by thin-layer chromatography (20 x 20 cm, 
2000 pm silica, 25 % ethyl acetate : hexane). 
b. Structural confirmation of the active ester of C2-CDA 
IR (neat, cm"1): 3320 (w, imide N-H), 2970-2880 (m, alkyl C-H), 1830, 1795, 1750, 
1690 (s, aliphatic, imide, 3° amide C=0), 1460-1370 (m, 3° arylamine C-N), 1240 - 1200 
(s, -CO.OR), 810 (m, 1,2,3 trisub aryl C-H). 'H NMR (200 Hz, CDC13): 5 1.2 (t, 6H, - 
CH3), 2.6 (q, 4H, alkyl -CH2), 2.7 (s, 4H, imide -CH2), 3.7 (s, 2H,-N-CH2-COOR), 4.5 (s, 
2H, Cl-CH2-CO.R), 7.2 (m, 3H, aryl CH). MS: m/z= 380 (M+), 266, 238, 216, 188, 162. 
Elemental analysis (theoretical values in parentheses): C: 57.13% (56.77%); H: 5.85% 
(5.56%); N: 7.0% (7.36%); O: 21.08% (21.00%); Cl: 8.93% (9.30%). 
c. Structural confirmation of the active ester of C4-CDA 
IR (neat, cm"1): 3400 - 3300 (w, imide N-H), 2940 (m, alkyl C-H), 1795, 1760, 1740, 
1650 (s, aliphatic, imide, 3° amide C=0), 1460-1320 (m, 3° arylamine C-N), 1200 (s, - 
CO.OR), 1050, 850 (m, 1,2,3 trisub aryl C-H). Elemental analysis (theoretical values in 
32 
parentheses): C: 59.58% (59.04%); H: 6.43% (5.70%); N: 6.69% (6.89%), O. 18.85 yo 
(19.66%); Cl: 8.45% (8.71%). 
d. Structural confirmation of the active ester of Phe-CDA 
IR (neat, cm’1): 3290 (s, imide N-H), 2940 (s, alkyl C-H), 1795, 1760, 1670, 1630 
(aliphatic, imide, 3° amide C=0), 1210 (s, -CO.OR), 1170, 1070 (m, 1,2,3 trisub aryl C- 
H), 870. 
2. Conjugation of CPA Haptens to Carrier Proteins 
a. Conjugation of active esters 
The activated esters of C2-CDA, C4-CDA and Phe-CDA, dissolved in THF, were 
stirred with protein (BSA, HSA or OVA) in phosphate -buffered saline (PBS) at 0 °C, at 
a 50:1 molar ratio (Table 2). The reaction was continued for 48 h at 4 °C. The conjugate 
solutions were dialyzed against dTCO (8-10 changes) at 4 °C and then lyophilized. 
b. Conjugation via N-acetyl homocysteinethiolactone 
CDA was also directly coupled to protein carrier molecules via N-acetyl homocysteine¬ 
thiolactone [AHT, Fig. 8, (Feng et al. 1992)]. The AHT thiolation of free amine groups 
on lysine residues of the protein carrier molecules provided a high density of reactive 
sites. Under basic conditions, the thiol groups spontaneously formed a covalent linkage 
with the chloroacetanilide moiety of CDA. Thus, BSA or OVA (200 mg) was dissolved 
in 6 ml dFfO. AHT (18.4 mg, 115 mmol) was added to the protein with stirring and the 
solution chilled to 0 °C. CDA dissolved in 1 ml dioxane was added dropwise and the 
reaction mixture adjusted to pH > 10 with carbonate - bicarbonate buffer (1.0 M, pH=l 1). 
After stirring at 0 C for an additional 15 min, the solution was transferred to a 50 °C 
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water bath and the reaction continued for 2 h. The reaction solution was neutralized with 
phosphate buffer (1.0 M, pH=7.2) and dialyzed against df^O (8 changes). The BSA- 
AHT-CDA conjugate was used for antibody production and the OVA-AHT-CDA 
conjugate was used as the ELISA plate-coating antigen. 
Hapten densities were determined by titrating free amine moieties with trinitrobenzene 
sulfonic acid (TNBS, Habeeb 1965, Table 2). The hapten - protein linkages for the four 
immunogens are shown in Figure 9. 
Table 2. Hapten Densities of Immunogens and Plate-Coating Antigens 









OVA4 5-Phe-CDA 16.8% 
OVA-AHT-CDA __5 
1. Hapten densities reported as percent of available lysine residues (free amines) 
BSA = 61; OVA = 20. 
2. Bovine serum albumin. 
3. Human serum albumin. 
4. Ovalbumin (chicken egg albumin). 
5. Unable to determine due to solubility problems. 
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Figure 8. Direct coupling of CD A to protein carrier molecules via N-acetyl homocysteine 
thoilactone (AHT). The protein was bovine serum albumin (BSA) for the immunizing 



























DEVELOPMENT OF A COMPETITION ENZYME-LINKED IMMUNOSORBENT 
ASSAY (cELISA) FOR THE DETECTION OF CD A AND HD A 
A. Antibody Production 
Immunizations and blood collections were performed by Animal Care and Research 
Services, Graduate School, University of Massachusetts, Amherst. Standard 
immunization protocols were followed (Coligan et al. 1995). Female white New Zealand 
rabbits (2-3 kg) were initially immunized with 250 jug hapten-protein conjugate 
solublized in 250 pi PBS (pH 7.2) and emulsified 1:1 with Freund’s complete adjuvant 
(Table 3). Groups of three rabbits were immunized with BSA-C2-CDA and BSA-C4- 
CDA, and two pairs of rabbits immunized with BSA-Phe-CDA and BSA-AHT-CDA 
(Table 4). Subsequent boosts of 250 pg hapten-protein conjugate in PBS, emulsified with 
Freund’s incomplete adjuvant, were administered at three week intervals. All injections 
were administered intradermally at multiple locations on the back. Approximately 10 ml 
blood was collected 7 to 10 days following each immunization. Serum was collected by 
centrifugation (i.e., 3500 rpm, 15 min, 4 C) and diluted 1:1 with glycerol. Thimerosal 
was added at 0.01% as a preservative and the sera were stored at -20 °C. 
B. Procedures for Enzyme Immunoassays 
Immunoassays were conducted on 96-well microtiter plates (Nunc). Plates were coated 
with hapten-protein conjugate in carbonate / bicarbonate buffer (0.05 M, pH 9.6, 
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Table 3. Hapten-Carrier Conjugates Used for Immunization and Plate Coating 
cELISA # Plate-Coating Antigen 
1 BSA'-C2-CDA HSA2-C2-CDA 
2 BSA-C4-CDA BSA-C4-CDA 
3 BSA-Phe-CDA OVA3-Phe-CDA 
4 bsa-aht4-cda OVA-AHT-CDA 
1. Bovine serum albumin. 
2. Human serum albumin. 
3. Ovalbumin (chicken egg albumin). 
4. N-acetyl homocysteine thiolactone. 
Table 4. Antisera Designations 
Immunogen Rabbit Number Serum Pool Number 
BSA-C2-CDA 1 RAX1 
2 RAX2 
41 RAX4 
BSA-C4-CDA 5 RAX5 
6 RAX6 
7 RAX7 
BSA-Phe-CDA 8 RAX8 
9 RAX9 
BSA-AHT-CDA 10 RAX10 
11 RAX11 
1. Rabbit # 3 died during initial immunization. 
50 jul/well) by incubating overnight at room temperature. After washing, plates were 
blocked with protein (0.25% OVA or BSA in PBS ammended with 0.05% Tween-20 
(PBST)). Dried plates were stored in zip-lock bags at 4 °C. 
















































analyte in solution competes with plate-bound antigen for CDA-specific antibody (i.e., 
primary antibody) binding. Maximum binding of antibody to plate-bound antigen occurs 
in the absence of analyte. The presence of analyte inhibits primary antibody binding to 
antigen in proportion to analyte concentration. Plate-bound antibodies are quantitated by 
addition of secondary antibody specific for primary antibody. The secondary antibody is 
conjugated to the reporter enzyme, horseradish peroxidase (HRP). Visualization of bound 
antibodies is accomplished with a tetramethylbenzidine / peroxide (TMB-H2O2) substrate 
system, which forms a colored product that is quantified spectrophotometrically. In this 
format, optical density (OD) is inversely proportional to analyte concentration. ODs were 
reported directly versus analyte concentration, or as percent ratios of control values (i.e., 
water blank) versus analyte concentration. The percent ratios %B/Bo were determined by 
the formula: 
%B/Bo = (ODsampie/ODControl)xlOO. 
The IC50, or concentration of analyte resulting in 50% inhibition of antibody binding, was 
extrapolated from plots of analyte concentration versus %B/Bo. 
Optimal concentrations of antisera, plate coating antigen and secondary reporter 
antibodies were determined by checkerboard assays utilizing standard procedures as 
outlined in Coligan et al. (1995) and Harlow and Lane (1988). Antisera diluted in PBST 
was added to the microtiter plate (50 pl/well) and incubated at 37 °C for 60 min. After 
washing, bound antibodies were quantified using goat anti-rabbit IgG antibodies 
conjugated to HRP (50 pl/well), incubated for 30 min at 37 °C. The TMB-H202 for HRP 
was prepared by diluting 200 pi TMB stock solution (25 mmol in DMSO) and 17 pi 
H202 (3% solution) in 12.5 ml sodium acetate buffer (0.1 M, pH 5.5). TMB- H202 (100 
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jul/well) was incubated for 10 to 25 min at room temperature and the reaction stopped by 
adding 50 pl/well 4 MH2SO4. OD was determined at 450 nm. In competition assays, 
solutions of CDA, HDA and cross-reactivity test compounds (from methanol or acetone 
stock solutions) were diluted in dE^O. Competitor solutions were added immediately 
prior to addition of primary antisera dilutions. The limit of detection was determined as 
the concentration that resulted in an OD value less the dH^O control mean OD value 
minus 3 standard deviations (Brady 1995). 
C. Competition Enzyme-Linked Immunosorbent Assays (cELISA) 
1. cELISA 1: Anti-BSA-C2-CDA Antisera 
a. Checkerboard assays 
Microtiter plates were coated with HSA-C2-CDA at 60, 125, 250, and 500 ng/well. 
Antisera RAX1, RAX2 and RAX4 were serially diluted 1:125, 1:500, 1:2000, 1:8000, 
1:32,000 in PBST. Goat anti-rabbit IgG-HRP was serially diluted 1:1250, 1:5000, 
1:10,000, 1:20,000, 1:40,000, 1:80,000 in PBST. Assays were run as described in section 
III.B. Results from a typical assay are presented in Table 5. 
b. Competition assays 
Standard solutions of CDA in dL^O were added to the plate prior to addition of primary 
antisera dilutions. Based on the results of the checkerboard assays, antisera RAX1, 
RAX2 and RAX3 were diluted 1:4000 in PBST. Goat anti-rabbit IgG-HRP was diluted 
1:40,000 in PBST. Binding of RAX1 antibodies was inhibited by CDA (Fig. 11) It was 
necessary, however, to incubate the initial competition step for 16 h in order to detect 
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Table 5. Checkerboard Assay for Antisera RAX1 versus BSA-C2-CDA and HSA- 
C2-CDA Plate-Coating Antigens 
BSA-C2-CDA|HSA-C2-CDA 
1° Ab: 1:125 1:500 1:2K 1:8K 1:32K Ctrl1 1:125 1:500 1:2K 1:8K 1:32K Ctrl 
2° Ab 1:1250 2.3492 1.827 1.366 0.996 0.552 0.292 2.936 2.646 2.067 1.738 1.116 0.357 
1:2500 2.241 1.619 1.131 0.654 0.408 0.270 2.640 2.288 1.866 1.734 0.730 0.449 
1:5000 1.878 1.409 0.766 0.469 0.317 0.188 2.450 2.178 1.775 1.014 0.498 0.307 
1;10K 1.458 0.941 0.507 0.274 0.204 0.141 2.253 2.055 1.129 0.668 0.299 0.266 
1:20K 1.356 0.617 0.410 0.180 0.107 0.081 1.936 1.512 0.730 0.440 0.255 0.199 
1:40K 0.850 0.448 0.243 0.115 0.075 0.067 1.597 0.947 0.498 0.203 0.159 0.103 
1:80K 0.510 0.365 0.174 0.094 0.069 0.064 1.186 0.746 0.374 0.211 0.147 0.100 
Ctrl 0.056 0.054 0.055 0.062 0.058 0.054 0.079 0.085 0.085 0.091 0.082 0.063 
1. Control (buffer only). 
2. OD determined at 450 nm. 
inhibition of antibody binding by CD A. The concentration range for inhibition was 1.0 to 
100 jag/ml CDA, which indicated that RAX1 antibodies had only slight recognition of 
CDA. RAX2 and RAX3 were not inhibited by CDA (i.e., did not recognize CDA) and 
were not further characterized, 
c. Cross-reactivity to related compounds 
RAX1 showed far greater affinity to alachlor than to the intended target analyte CDA 
(Fig. 11). The detection range was 0.05 to 100 jug/ml alachlor. Thus, BSA-C2-CDA did 
not result in the production of CDA- specific antibodies. 
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Figure 11. Competitive inhibition of antiserum RAX1 by CDA and alachlor. Microtiter 
plates were coated with 60 ng/well HSA-C2-CDA. Antiserum RAX1 was diluted 
1:20,000 in PBST. Goat anti-rabbit IgG was diluted 1:10,000 in PBST. Absorbance 
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2. cELISA 2: Anti-BSA-C4-CDA Antisera 
a. Checkerboard assays 
Microtiter plates were coated with BSA-C4-CDA at 60, 125, 250, and 500 ng/well. 
Antisera RAX5, RAX6 and RAX7 were serially diluted 1:1,000, 1:5,000, 1:10,000 and 
1:20,000 in PBST. Goat anti-rabbit IgG-HRP was serially diluted 1:5,000, 1:10,000, 
1:20,000 and 1:40,000 in PBST. Assays were run as described in section III.B. Typical 
results are shown in Table 6. 
b. Competition assays 
Standard solutions of CDA and alachlor in dH^O were added to the plate prior to 
addition of primary antisera dilutions. Based on the results of the checkerboard assays, 
antisera RAX5, RAX6 and RAX7 were diluted 1:2,000 in PBST. Goat anti-rabbit IgG- 
HRP was diluted 1:5,000 in PBST. Binding of RAX7 was only slightly inhibited by 
CDA, which resulted in an IC50 value greater than 100 jag/ml (Fig. 12). Alachlor, 
however, showed greater inhibition with an IC50 value of 3 jug/ml (Fig. 12). Binding of 
RAX5 and RAX6 showed a similar affinity for alachlor but not for CDA and were not 
further characterized. 
c. Cross-reactivity to related compounds 
The inhibition of RAX7 antiserum by the chloroacetanilide herbicides acetochlor, 
butachlor, metolachlor and propachlor (Fig. 13) was determined in competition assays 
over the concentration range 0.05 to 100 pg/ml. Although RAX7 responded to alachlor, 
cross reactivity to these structurally-related compounds was negligible (Table 7). Thus, 
BSA-C4-CDA also did not result in the production of CDA-specific antibodies. 
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Table 6. Checkerboard Assay for the Detection of BSA-C4-CDA by Antisera RAX5, 
RAX6 and RAX7 
1° Ab: RAX 5_ RAX6_RAX 7_ 
1° Ab Dilution VAK U5K 1:10K 1:20K 1:1K 1:5K 1:1QK 1:20K 1:1K 1:5K 1.10K 1:2QK 
2° Ab 1:5K 1.0201 0.829 0.701 1.159 1.090 0.889 1.524 1.414 1.223 1.535 1.448 1.218 
1.000 0.815 0.646 1.103 1.020 0.851 1.475 1.282 1.186 1.446 1.402 1.310 
2° Ab 1:10K 0.837 0.734 0.576 1.171 0.955 0.763 1.394 1.309 1.091 1.460 1.380 1.187 
0.056 0.047 0.041 0.044 0.042 0.042 0.044 0.042 0.042 0.044 0.043 0.048 
2° Ab 1:20K 0.969 0.776 0.612 1.203 1.070 0.733 1.504 1.354 1.212 1.540 1.426 1.292 
0.736 0.631 0.435 1.120 0.900 0.698 1.425 1.195 1.074 1.552 1.365 1.228 
2° Ab 1:40K 0.755 0.597 0.426 0.963 0.842 0.611 1.312 1.138 0.955 1.399 1.214 1.072 
0.056 0.049 0.044 0.052 0.052 0.052 0.053 0.058 0.048 0.056 0.053 0.047 
1. OD determined at 450 nm. 
Table 7. Cross-Reactivity (Reported as IC50) of Chloroacetanilide Herbicides to 
Antiserum RAX7 
Alachlor 3 jag/ml Metolachlor >100 jag/ml 
Acetochlor >100 jag/ml Propachlor >100 jag/ml 
Butachlor >100 jag/ml 
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Figure 12. Competitive inhibition of antiserum RAX7 by CDA and alachlor. Microtiter 
plates were coated with 60 ng/well BSA-C4-CDA. Antiserum RAX7 was diluted 
1:20,000 in PBST. Goat anti-rabbit IgG was diluted 1:5,000 in PBST. Absorbance 
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Figure 13. Structures of chloroacetanilide herbicides and related compounds tested for 
cross-reactivity. I, alachlor; II, hydroxyalachlor; III, alachlor ethanesufonic acid (alachlor- 
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3. cFT.ISA 3: Anti-BSA-Phe-CDA Antisera 
a. Checkerboard assays 
Microtiter plates were coated with OVA-Phe-CDA at 0.5, 1.0, 5.0, and 10.0 ng/well. 
Antisera RAX10 and RAX 11 were serially diluted 1:5000, 1:10,000 and 1:20,000 in 
PBST. Goat anti-rabbit IgG-HRP was serially diluted 1:5,000, 1:10,000 and 1:20,000 in 
PBST. Assays were run as described in section III.B. Results are shown in Table 8. 
b. Competition assays 
Initial competition assays showed that RAX11 but not RAX 10 specifically recognized 
CD A in solution. RAX11 was used in all subsequent competition assays (Fig. 14). A 
stock solution of CDA in acetone was serially diluted in dH20 to concentrations of 100, 
33.3, 11.1, 3.7, 1.2, 0.4, 0.14, 0.04, 0.015, and 0.005 pg/ml and added to a microtiter plate 
contaning 1.0 ng/well OVA-Phe-CDA. RAX11, diluted 1:20,000 in PBST, was added 
and the plate incubated 60 min at 37 °C. After washing the plate of unbound antibodies, 
goat-anti rabbit IgG-HRP, diluted 1:10,000 in PBST, was added and incubated 30 min at 
37 °C. The TMB enzyme substrate was incubated 30 min at room temperature and the 
reaction stopped with 4M H2S04. The linear range of CDA detection was 0.015 to 10 
ug/ml with an IC50 value of 2 ug/ml. 
c. Cross-reactivity to related compounds 
The cross-reactivities of RAX11 to compounds structurally related to CDA (Fig. 13) 
were determined by competition assays over the concentration range 100 to 0.4 pg/ml. 
The IC50 values were extrapolated from plots of %B/Bo versus concentration. Percent 
cross reactivity (%R) was quantitated as: 
%R = [ICso (CDA) / IC50 (test compound)] x 100. 
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RAX11 specifically detected CD A and showed no cross reactivity to alachlor, other 
alachlor metabolites, or other chloroacetanilide herbicides (Table 9). Thus, the 
immunogen BSA-Phe-CDA resulted in the production of CDA-specific antibodies. 
Table 8. Checkerboard Assay for the Detection of OVA-Phe-CDA by Antisera 
RAX10 and RAX11 
OVA-Phe-CDA: 0,5 ng/well_1.0 ng/well 5.0 ng/well 10.0 ng/well 
2° Ab: 1:5K 1:10K 1:20K 1 1:5K 1:1 OK 1:20K 1 1:5K 1:10K 1:20K 1 1:5K 1:10K 1:20K 
RAX10 1:5K 1.020 1 0.829 > 0.701 1.159 1.090 0.889 1.524 1.414 1.223 1.535 1.448 1.218 
1:1 OK 1.000 0.815 0.646 1.103 1.020 0.851 1.475 1.282 1.186 1.446 1.402 1.310 
1:20K 0.837 0.734 0.576 1.171 0.955 0.763 1.394 1.309 1.091 1.460 1.380 1.187 
No 1° Ab 0.056 0.047 0.041 0.044 0.042 0.042 0.044 0.042 0.042 0.044 0.043 0.048 
RAX11 1:5K 0.969 0.776 0.612 1.203 1.070 0.733 1.504 1.354 1.212 1.540 1.426 1.292 
1:10K 0.736 0.631 0.435 1.120 0.900 0.698 1.425 1.195 1.074 1.552 1.365 1.228 
1:20K 0.755 0.597 0.426 0.963 0.842 0.611 1.312 1.138 0.955 1.399 1.214 1.072 
No 1° Ab 0.056 0.049 0.044 0.052 0.052 0.052 0.053 0.058 0.048 0.056 0.053 0.047 
1. OD determined at 450 nm. 
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Figure 14. Competitive inhibition of antiserum RAX11 by CD A. Microtiter plates were 
coated with 1 ng/well OVA-Phe-CDA. Antiserum RAX11 was diluted 1:20,000 in PBST. 
Goat anti-rabbit IgG was diluted 1:10,000 in PBST. Absorbance values (OD) are the 
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Table 9. Cross-Reactivity of RAX11 to Chloroacetanilide Herbicides and Related 
Compounds 
Compound Concentration %B/Bo' ca. IC502 %R3 
Alachlor 100 pg/ml 86.2% > 100 jug/ml <0.1% 
2,6-DEA 100 jLig/ml 100.6% >100 jug/ml <0.1% 
Hydroxyalachlor 100 pg/ml 98.9% > 100 jag/ml <0.1% 
HDA 100 pg/ml 91.0% > 100 jag/ml <0.1% 
ESA-alachlor 100 pg/ml 94.8% > 100 pg/ml <0.1% 
Acetochlor 100 pg/ml 93.4% > 100 pg/ml <0.1% 
Butachlor 100 jug/ml 99.9% > 100 jug/ml <0.1% 
Metolachlor 100 pg/ml 88.3% > 100 pg/ml <0.1% 
Propachlor 100 pg/ml 101.6% >100 pg/ml <0.1% 
1. Percent ratio of bound antibody compared to dH20 control. 
2. Concentration resulting in 50% inhibition of antibody binding versus dH20 control. 
3. Cross reactivity compared to CDA. %R=[IC5o (CDA) / IC50 (test compound)] x 100. 
d. Assay Optimization 
i. pH effects. The effect of pH on assay performance was determined with pH adjusted 
dH20 over the range pH 4.0 to 9.5 in 0.5 pH increments. The standard cELSIA format 
was run with no analyte present (i.e., pH adjusted dH20 only) or with a concentration of 
CDA that resulted in 50% inhibition of antibody binding (i.e., 2 pg/ml). The inhibition of 
antiserum RAX11 by CDA was unaffected by pH over the entire range tested (Fig. 15). 
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Figure 15. Effect of aqueous sample pH on binding of antiserum RAX11. 
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Sample pH Value 
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ii. Solvent effects. To determine the effect of solvents on assay performance, the 
standard cELSIA format was run with standards of CD A over the concentration range 0.1 
to 10 pg/ml made up in 10%, 25% or 50% methanol, ethanol, acetone or acetonitrile in 
dH20. Methanol and ethanol concentrations up to 10% did not adversely effected the 
signal generated (Table 10). However, higher concentrations of these solvents, and as 
little as 10% acetone or acetonitrile, resulted in a reduction in OD signal reduction of 20 
to 60%. Therefore, use of these solvents for extraction processes prior to anlysis by 
cELISA 3 would require solvent removal and reconstitution in dH20 or buffer. 
Table 10. cELISA3 Signal Attenuation Due to the Effect of Solvents on Antibody 
Binding 
Solvent Concentration Percent Signal Reduction1 
Methanol Ethanol Acetone Acetonitrile 
10% (v/v) 2.6 ±2.3 11.5 + 5.8 19.8 ± 10.0 26.9 ± 10.8 
25% 18.4 ±2.4 37.2 + 3.6 21.4 ± 11.8 39.8 ±9.6 
50% 20.5 ±3.1 61.4 + 3.3 17.2 ±8.6 57.7 ±9.7 
1. Percent reduction in OD compared to dH20 control. Values are averages 
(n = 8) ± standard deviation of duplicate determinations over the concentration range 
0.1- 10 pg/ml. 
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4. cELISA 4: Anti-BSA-AHT-CDA Antisera 
a. Checkerboard assays 
Microtiter plates were coated with OVA-AHT-CDA at 1.0, 10.0, 25.0 and 50.0 ng/well. 
Antisera RAX8 and RAX9 were serially diluted 1:5000, 1:10,000 and 1:20,000 in PBST. 
RAX8 showed a high CDA-specific antibody titer and was diluted 1:25,000, 1:50000, 
1:100,000 and 1:200,000 in susequent checkerboard assays. Goat anti-rabbit IgG-HRP 
was serially diluted 1:10,000 and 1:20,000 in PBST. Assays were run as described in 
section III.B. Results for RAX8 are shown in Table 11. 
b. Competition assays 
Initial competition assays showed that both RAX8 and RAX9 specifically recognized 
CDA and HDA in solution. RAX8 produced a more satisfactory competition curve and 
was used in all subsequent competition assays (Fig. 16) A stock solution of 10 mg/ml 
CDA in acetone was serially diluted in dH20 to concentrations of 100, 33.3, 11.1, 3.7, 
1.2, 0.4, 0.14, 0.04, 0.015, and 0.005 pg/ml and added to a microtiter plate containing 1.0 
ng/well OVA-AHT-CDA. RAX8, diluted 1:50,000 in PBST, was added and the plate 
incubated 60 min at 37 °C. After washing the plate of unbound antibodies, goat-anti 
rabbit IgG-HRP, diluted 1:10,000 in PBST, was added and incubated 30 min at 37 °C. 
The TMB enzyme substrate was incubated 30 min at room temperature and the reaction 
stopped with 4M H2S04. The linear range of detection for CDA and HDA was 0.01 to 
10 ug/ml with an IC50 value of 0.2 ug/ml. 
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Table 11. Checkerboard Assay for the Detection of OVA-AHT-CDA by Antiserum 
RAX8 
1° Ab: 1:25,000_1:50,000_1:100,000 1:200,000 
2° Ab 1:1 OK 1.0201 0.829 0.701 1.159 1.090 0.889 1.524 1.414 1.223 1.535 1.448 1.218 
1.000 0.815 0.646 1.103 1.020 0.851 1.475 1.282 1.186 1.446 1.402 1.310 
0.837 0.734 0.576 1.171 0.955 0.763 1.394 1.309 1.091 1.460 1.380 1.187 
No 1° Ab 0.056 0.047 0.041 0.044 0.042 0.042 0.044 0.042 0.042 0.044 0.043 0.048 
1:20K 0.969 0.776 0.612 1.203 1.070 0.733 1.504 1.354 1.212 1.540 1.426 1.292 
0.736 0.631 0.435 1.120 0.900 0.698 1.425 1.195 1.074 1.552 1.365 1.228 
0.755 0.597 0.426 0.963 0.842 0.611 1.312 1.138 0.955 1.399 1.214 1.072 
No 1° Ab 0.056 0.049 0.044 0.052 0.052 0.052 0.053 0.058 0.048 0.056 0.053 0.047 
1. Optical density at 450 nm. 
c. Cross-reactivity to related compounds 
The cross-reactivity of antiserum RAX8 to compounds structurally related to CDA and 
HDAwas determined as described in section III.C.3.iii. RAX8 showed minimal cross¬ 
reactivity to alachlor, hydroxyalachlor and 2,6-diethylaniline, but did not cross-react with 
the chloroacetanilide herbicides acetochlor, butachlor, metolachlor and propachlor (Table 
12). Thus, the immunogen BSA-AHT-CDA resulted in the production of antibodies 
specific for CDA and HDA. 
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Figure 16. Competitive inhibition of antiserum RAX8 by CD A and HD A. Microtiter 
plates were coated with 1 ng/well OVA-AHT-CDA. Antiserum RAX8 was diluted 
1:50,000 in PBST. Goat anti-rabbit IgG was diluted 1:10,000 in PBST. Absorbance 
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Table 12. Cross-Reactivity of Antiserum RAX8 to Chloroacetanilide 
Herbicides and Related Compounds 
Compound IC5o' %R2 
Alachlor 28 jig/ml 0.7% 
2,6-DEA 10 jug/ml 2% 
Hydroxyalachlor 28 pg/ml 0.7% 
ESA-alachlor > 100 jug/ml <0.2% 
Acetochlor > 100 pg/ml <0.2% 
Butachlor >100 jag/ml <0.2% 
Metolachlor > 100 jug/ml <0.2% 
Propachlor >100 jug/ml <0.2% 
1. Concentration resulting in 50% inhibition of antibody binding versus dH20 control. 
2. Cross reactivity compared to CDA. %R=[IC50 (CDA) / IC50 (test compound)] x 100. 
d. Assay optimization 
i. pH effects. The effect of pH on assay performance was determined with pH adjusted 
dH20 over the range pH 4.0 to 9.5 in 0.5 pH increments. The standard cELSIA format 
was run with no analyte present (i.e., pH adjusted dH20 only) or with a concentration of 
CDA that resulted in 50% inhibition of antibody binding (i.e., 0.2 jag/ml). The inhibition 
of antiserum RAX8 by CDA was optimal between pH 7-8, but was not adversely 
affected by pH over the entire range tested (Fig. 17). 
iL Solvent effects. The effect of solvents commonly used in sample extraction on assay 
performance was determined by diluting CDA standards in the concentration range 0.1 - 
10 pg/ml in 10 to 50% solutions of methanol, ethanol, acetone. 
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or acetonitrile / CIH2O. Assays were performed using the standard format. Methanol and 
acetone did not adversely effect assay performance, resulting in only 5 - 15% signal loss 
at concentrations up to 50% (Table 13). Ethanol resulted in a 25 - 64% loss of signal, 
most likely due to denaturing of antibody protein. Acetonitrile resulted in a 31 - 38% 
signal loss. In summary, up to 50% sample concentrations of methanol or acetone are 
acceptable, however ethanol or acetonitrile should be avoided for extraction purposes or 
solvent-switched before the assay. 
Table 13. cELISA4 Signal Attenuation Due to the Effect of Solvents on Antibody 
Binding 
Solvent Concentration Percent Signal Reduction1 
Methanol Ethanol Acetone Acetonitrile 
10% (v/v) 7.8 25.2 14.1 38.2 
25% 4.7 30.3 14.7 31.1 
50% 5.7 63.4 12.9 37.6 
1. Percent reduction in OD compared to dH20 control. Values are averages of duplicate 
determinations with coefficients of variation less than 10%. 
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D. cELISA Validation 
1. Solid Phase Extraction of Aqueous Samples 
CDA and HDA were extracted from aqueous samples using Oasis™ HLB (3cc, 60 mg) 
solid phase extraction cartridges (Waters, Medford, MA). Fortified samples were 
prepared by fortifying tap water with stock solutions of CDA or HDA (1.0 mg/ml in 
acetone). The cartridges were conditioned with 6 ml of methanol followed by 6 ml dH20. 
Aqueous samples (100 - 1000 ml) were loaded onto the columns at a flow rate of 5 - 10 
ml/min. The cartridges were dried by maintaining the vacuum for 5 min and CDA or 
HDA residues were eluted with 1.0 ml methanol. Both compounds were quantitatively 
recovered from fortified aqueous samples in the range 10- 500 ng/L (Table 14). The 
extracts were diluted 1:4 in dH20 for cELISA analysis or injected undiluted for analysis 
by GC/MS. 
Solid phase extraction of 1 L aqueous samples results in an analyte concentration factor 
of 1000. When this sample preconcentration is used, the limit of detection for CDA by 
CELISA3 is 15 ng/ml / 1000 = 15 pg/ml or 15 parts per trillion. The limit of detection for 
CDA and HDA by cELISA4 is 10 pg/ml. The correlation of fortified aqueous sample 
concentrations of CDA and HDA to concentration determined by cELISA3 and cELISA4 
in the range 0.01 to 1 ng/ml showed good agreement (Figs. 18 and 19). For cELISA3, the 
slope of the CDA correlation line was 0.951 with an r2 value of 0.991. For cELISA4 , 
the slope of the CDA line was 0.996 with an r2 value of 0.996. The slope of the HDA 
line was 0.764 with an r2 value of 0.991. Therefore, the combination of solid phase 
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extraction and cELISA detection was suitable for the part per trillion analysis of CDA and 
HD A from water samples. 
Table 14. Recovery of CDA and HD A from Fortified Water Samples by 
Solid Phase Extraction 
Fortification Level (ng/L) CDA % Recovery1 HDA % Recovery 
10.0 107.3 ± 16.0 88.0 ±4.5 
20.0 100.0 ±25.8 85.1 ±7.0 
50.0 113.2 ±1.7 88.5 ± 1.7 
500.0 113.8 ± 11.0 87.0 ±4.8 
1. Mean value ± standard deviation, n=3. 
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Figure 18. Correlation of fortified sample CDA concentration with CDA 
detected by cELISA3. 
concentration 
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Figure 19. Correlation of fortified sample CD A and HD A concentration with CD A and 






























2. Chromatographic Analysis of Aqueous Sample Extracts 
Extracts of aqueous samples were analyzed by gas chromatography on a Hewlett- 
Packard HP5890 Series II equipped with an HP5971 Mass Selective Detector. The 
column was a 30 M x 0.25 mm DB-5, 0.25 ju film (J&W, Folsom, CA) programmed 
from 100 °C (1 min hold) to 250 °C (0.5 min hold) at 20 °C/min. The injector temperature 
was 250 °C and the transfer line was held at 280 °C. Injection volume was 2 pi. The 
detector was operated in the selected ion monitoring mode (SIM) for ions 225, 176 and 
147 (CDA) and 207, 176 and 147 (HDA). 
3. Correlation of cELISA and Chromatographic Analysis of Aqueous Samples 
CDA and HDA fortified aqueous samples were split for analysis by GC/MS and by 
cELISA3 (CDA-specific) and cELISA4 (CDA/HDA specific) to determine the accuracy 
of the cELISAs. Samples were prepared by solid phase extraction (section III.D.l) for 
chromatographic analysis. Samples in the concentration range 0.1 to 10 pg/ml were 
analyzed directly by cELISA. Samples in the concentration range 0.01 to 10 ng/ml were 
prepared by solid phase extraction as above. cELISA3 showed close correlation with 
GC/MS results for the detection of CDA (slope = 0.933 ; r2 =0.992; Fig. 20). cELISA4 
also showed a close correlation with GC/MS results for CDA (slope = 0.834; r2 =0.998; 
Fig. 21), but it underestimated HDA concentration (slope = 0.579; r2 =0.990; Fig. 21). 
4. cELSIA Analysis of Alachlor-Contaminated Groundwater Samples for CDA 
Groundwater previously determined to be contaminated with alachlor was analyzed by 
cELISA3 for the presence of CDA. Two samples were from a routine groundwater 
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monitoring project in Massachusetts and one sample was a composite of archived water 
samples from the USGS Laboratory in Lawrence, Kansas. Sample volumes were limited, 
therefore it was not possible to perform the CDA/HDA analysis by cELISA4. The 
samples were prepared by solid phase extraction as described above. CDA was detected 
in the two Massachusetts samples but not in the Kansas sample (Table 15). Results were 
confirmed by GC/MS analysis. The limited size of the Kansas sample raised the 
detection limit by a factor of 10, limiting the ability to determine the presence of CDA in 
this sample. 
This limited analysis of real-world samples demonstrates the ability of cELISA3 to 
specifically detect CDA in groundwater samples. 
Table 15. Analysis of Alachlor-Contaminated Groundwater Samples 
Sample Sample Volume CDA Concentration (ng/ml)1 
CELISA3 GC/MS 
Mass. C7308 500 ml 0.024 ± 0.007 0.020 ± 0.004 
Mass. B7557 500 ml 0.015 + 0.009 0.016 + 0.005 
Kansas USGS 75 ml n/d2 n/d 
1. Average concentration + SD, n=2. 
2. None detected at detection limits of 0.15 ng/ml (cELISA3) and 0.10 ng/ml (GC/MS). 
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Figure 20. Correlation of CD A detection by cELISA3 with GC/MS. 
\ 
78 
CDA Concentration (ug/ml) Determined by GC/MS 
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Figure 21. Correlation of CD A and HD A detection by cELISA4 with GC/MS. 
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CHAPTER IV 
DISCUSSION AND CONCLUSIONS 
A. Hapten Design 
The target analytes CDA and HDA are small molecules (MW 225 and 207, 
respectively) and are not immunogenic. It was necessary, therefore, to attach them to 
large carrier protein molecules in order to elicit the immunogenic response that would 
result in the production of specific antibodies. Antibody specificity encompasses not only 
recognition of the intended target analyte but also a lack of cross-reactivity to structurally 
related compounds (i.e., the parent compound alachlor, other alachlor metabolites, and 
other chloroacetanilide herbicides). The attachment of CDA or HDA to protein 
molecules necessitated the synthesis of chemical derivatives (i.e., haptens) that would 
provide a covalent linkage as well as present the hapten for antibody recognition in a 
manner that maximized the unique structural features of CDA and HDA. 
The structural differences between CDA and HDA, alachlor, other alachlor 
metabolites, and other chloroacetanilide herbicides are: 1) the degree of saturation at the 
nitrogen atom and 2) alkyl substitution at the 2 and 6 positions on the aromatic ring 
(Figs. 1 and 13). The parent herbicides are fully saturated at the nitrogen atom (i.e., they 
are tertiary amines), whereas CDA, HDA and most other metabolites are secondary amine 
compounds. Alachlor and butachlor (and their metabolites) have ethyl substitutions at the 
2 and 6 positions of the aromatic ring. Acetochlor and metolachlor (and their 
metabolites) have one ethyl and one methyl substitution at these positions. Propachlor 
(and its metabolites) contains a nonsubstituted aromatic ring. Therefore, the degree of 
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saturation at the nitrogen atom and the type of alkyl substitution on the aromatic ring 
would be expected to govern any potential cross-reactivity to CDA and HDA specific 
antibodies. 
HDA can be synthesized from CDA by a simple hydrolysis reaction. Therefore, hapten 
synthesis focused on CDA, with the recognition that the corresponding HDA hapten 
could be synthesized in a similar manner with the addition of a hydrolysis step to the 
reaction sequence. There were four candidate sites on CDA for use as covalent binding 
sites to the carrier protein: 1) the nitrogen atom, 2) the chloroacetanilide chlorine atom, 3) 
the ethyl side chains of the aromatic ring and 4) the aromatic ring itself (Fig. 22). 
The C2-CDA and C4-CDA haptens featured a 2- or 4-carbon linkage group, 
respectively, attached to the nitrogen atom. The use of the nitrogen atom of CDA as the 
linkage site had the advantage of straight-forward synthetic procedures to produce the 
desired hapten. Anitsera produced in response to the BSA-C2-CDA immunogen 
demonstrated greater affinity for alachlor than for CDA. The length of the linkage group 
also influences hapten presentation for antibody recognition (Goodrow et al. 1995). 
Therefore, the BSA-C4-CDA was synthesized with a 4-carbon spacer to replace the 2- 
carbon spacer of C2-CDA. Anitsera produced in response to BSA-C4-CDA showed a 
greater affinity to CDA than did BSA-C2-CDA antibodies. However, it still elicited far 
greater affinity for alachlor. This finding demonstrated clearly that the saturation state of 
the amine moiety was crucial for selective antibody recognition. By utilizing the nitrogen 
atom of CDA for the linkage site, the resulting hapten contained a tertiary amine moiety 
that more closely resembled alachlor than the secondary amine CDA. It is now apparent 
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that this hapten synthesis strategy is unsuitable for the production of CDA or HDA 
specific antibodies. 
The Phe-CDA hapten featured a 5-carbon linkage group attached to carbon 4 of the 
aromatic ring of CDA. This linkage strategy was used successfully by Schlaeppi et al. 
(1991) for the synthesis of a haptenic derivative of metolachlor. The attachment of a 
linker group directly to the aromatic ring involved a more complicated synthesis, but the 
resulting hapten had the advantage of preserving the saturation state of the secondary 
amine moiety of CDA. The length of the linkage also insured that the hapten was 
physically distant enough from the carrier protein surface that the alkyl side chains on the 
aromatic ring could also contribute to antibody recognition. Anitsera produced in 
response to BSA-Phe-CDA specifically recognized CDA, but did not recognize HDA. 
Apparently, this antisera (i.e., RAX11) elicited adequate specificity to distinguish 
between the chlorine atom of CDA and the hydroxyl moiety of HDA, the sole difference 
between these two molecules. RAX11 also did not cross-react with alachlor, other 
alachlor metabolites or other chloroacetanilide herbicides. The lack of cross-reactivity to 
alachlor-ESA is particularly significant because this compound was found to be a major 
cross-reactive interference with commercial alachlor immunoassays that resulted in a 
number of false-positive reports for alachlor (Baker, et al. 1993). Thus, by preserving the 
unique acetanilide moiety of CDA in the hapten design, the goal of producing CDA 
specific antibodies was achieved. 
The use of the chlorine atom of CDA as a linkage site avoided the synthesis of a unique 
hapten altogether by allowing direct coupling of CDA to BSA through the coupling 
reagent AHT. Feng et al. (1992) successfully utilized this approach to create hapten 
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carrier conjugates for a variety of chloroacetanilide compounds. Although the BSA- 
AHT-CDA immunogen preserved the secondary amine state in the hapten, this linkage 
strategy eliminated the only distinguishing structural feature between CDA and HDA ( 
i.e., the chlorine atom and the hydroxyl group, respectively). Therefore, antisera 
produced in response to the BSA-AHT-CDA immunogen (i.e., RAX8) recognized both 
CDA and HDA but distinguished these compounds from alachlor, other alachlor 
metabolites and other chloroacetanilides. The minimal cross reactivity of RAX8 to 
alachlor, hydroxyalachlor and 2,6-diethylaniline indicates that in addition to the saturation 
state of the amine, the ethyl substitution at the 2 and 6 positions of the aromatic ring also 
plays an important role in antibody recognition. 
Various haptenic derivatives of an acetanilide compound, CDA, produced antisera with 
differing specificities. These results clearly indicate that for the production of antisera 
specific for acetanilides, the degree of saturation of the amine moiety is of primary 
importance and must be preserved in the hapten design. Alkyl substitution in the 
aromatic portion of the molecule is of secondary importance, but does play a role in 
antibody recognition. 
B. The CDA and CD A/HD A cELISAs 
cELISA3 was based on antiserum RAX11, which specifically detected CDA. The 
range of detection was 0.015 to 10 pg/ml, with an IC50 of 2 jug/ml. The detection range 
of cELSIA in general can be in the low part per billion range, so cELISA3 is not at the 
limits of immunoassay sensitivity. Additionally, a heterologous assay system was used in 
which different protein carriers were used for raising antisera and for the plate-coating 
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antigen. This insured that only CDA-specific antibodies would react in the assay and 
insured that antibodies that recognized the BSA carrier protein would not cause 
interference and compromise sensitivity. One possible means of enhancing the sensitivity 
of cELISA 3 would be through the purification of antiserum RAX11 by affinity 
chromatography (Szekacs and Hammock 1995). 
Solid phase extraction procedures were developed for extraction of CDA from aqueous 
samples. It was possible to effect a 1000-fold concentration of CDA. Thus, the effective 
detection limit for CDA in aqueous samples was lowered to 15 parts per trillion (pg/ml) 
by SPE/cETISA3 analysis. Also, cELISA3 did not cross-react with HD A, alachlor or its 
other metabolites, or other chloroacetanilide herbicides. 
Groundwater or surface water samples exhibit a range of pH values, so it was important 
to assess the influence of pH on the assay. The pKas of CDA and HDA are unknown, but 
for the parent aniline the pKa > 27 (Harris and Hayes 1982). Therefore, the amine 
moieties of CDA and HDA most likely are ionized only in very acidic conditions, so any 
potential influence of pH on the assay would be on antibody binding rather than on the 
ionization state of the target analytes. cELISA3 was shown to be stable to changes in 
sample pH, due to the buffering effects of the antiserum solution buffer. 
Polar solvents are utilized for the extraction of CDA from soil and other environmental 
samples, as well as in the solid phase extraction procedures used for aqueous samples. 
cELSIA3 is adversely effected by the solvents acetone and acetonitrile, but is stable to 
low concentrations (i.e., 10% or less) of methanol and ethanol. 
cELISA4 was based on antiserum RAX8, which specifically detected CDA and HDA. 
The range of detection was 0.01 to 10 (ag/ml, with IC50s of 0.5 (.ig/ml for CDA and 0.3 
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pg/ml for HDA. This assay also used a heterologous design, with different carrier 
proteins for the immunizing and plate-coating conjugates. Identical competition curves 
for CDA and HDA would be expected based on the hapten design. The slight differences 
in the shapes of the competition curves and for the IC50S are likely due to differences in 
the water solubilities of the two compounds. Other contributing factors are steric 
differences between CDA and HDA (i.e., the chlorine of CDA versus the hydroxyl group 
of HDA), and the response of different portions of the polyclonal antibody pool to each 
compound. 
The solid phase extraction procedures developed for CDA were also effective for HDA. 
The effective detection limit for the combined SPE/cELISA4 analysis of CDA and HDA 
from aqueous samples was 10 parts per trillion (pg/ml). cELISA4 did not cross-react 
with alachlor, its metabolites or other chloroacetanilide herbicides. It was stable to 
changes in sample pH, due to the buffering effects of the antiserum solution buffer. It 
was adversely effected by the solvents ethanol and acetonitrile, but was stable to sample 
concentrations of up to 50% methanol or acetone. 
C. Conclusions 
Two cELISAs have been developed for the specific detection of 2-chloro-2’,6’-diethyl- 
acetanilide (CDA) and 2-hydroxy-2’,6’-diethylacetanilide (HDA), two mutagenic 
metabolites of the chloroacetanilide herbicide alachlor. cELISA3 is specific for CDA 
with a detection range of 0.015 to 10 pg/ml. Solid phase extraction of CDA residues from 
aqueous samples gives a 1000-fold concentration factor resulting in an effective detection 
limit of 15 pg/ml. cELISA4 is specific for both CDA and HDA in combination, with a 
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detection range of 0.01 to 10 jug/ml. Solid phase extraction of aqueous samples prior to 
cELISA analysis results in an effective detection limit of 10 pg/ml. Chloroacetanilide 
herbicides and other alachlor metabolites that may be present in environmental samples 
do not interfere with the detection of CD A and HD A. 
The CDA and CDA/HDA cELISAs provide the means of monitoring for these two 
mutagens in the environment. The availability of the CDA and CDA/HDA specific 
antisera provides a means for analyte-specific preconcentration of samples for use in 
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